JP2024514308A5 - - Google Patents
Info
- Publication number
- JP2024514308A5 JP2024514308A5 JP2023560349A JP2023560349A JP2024514308A5 JP 2024514308 A5 JP2024514308 A5 JP 2024514308A5 JP 2023560349 A JP2023560349 A JP 2023560349A JP 2023560349 A JP2023560349 A JP 2023560349A JP 2024514308 A5 JP2024514308 A5 JP 2024514308A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- domain
- molecule according
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163168210P | 2021-03-30 | 2021-03-30 | |
| US63/168,210 | 2021-03-30 | ||
| PCT/US2022/022575 WO2022212525A2 (en) | 2021-03-30 | 2022-03-30 | Car t cell therapy and ifn gamma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514308A JP2024514308A (ja) | 2024-04-01 |
| JP2024514308A5 true JP2024514308A5 (https=) | 2025-04-08 |
Family
ID=81384825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560349A Pending JP2024514308A (ja) | 2021-03-30 | 2022-03-30 | ＣＡＲ Ｔ細胞療法及びＩＦＮγ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240366662A1 (https=) |
| EP (1) | EP4314040A2 (https=) |
| JP (1) | JP2024514308A (https=) |
| CN (1) | CN117242090A (https=) |
| WO (1) | WO2022212525A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025235801A1 (en) | 2024-05-08 | 2025-11-13 | City Of Hope | Antibodies targeted to osteopontin and uses thereof for reducing resistance of solid tumors immune cell therapy |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2331566B1 (en) * | 2008-08-26 | 2015-10-07 | City of Hope | Method and compositions for enhanced anti-tumor effector functioning of t cells |
| CN113307880B (zh) * | 2014-01-13 | 2025-07-04 | 希望之城公司 | 在Fc间隔物区中具有突变的嵌合抗原受体(CAR)及其使用方法 |
| BR112017005631A2 (pt) | 2014-09-19 | 2018-06-26 | City Of Hope | células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2 |
| KR102558502B1 (ko) * | 2014-12-05 | 2023-07-20 | 시티 오브 호프 | Ｃｓ1 표적화된 키메라 항원 수용체-변형된 ｔ 세포 |
| EP3359574B1 (en) | 2015-10-06 | 2020-04-22 | City of Hope | Chimeric antigen receptors targeted to psca |
| IL302560B2 (en) * | 2015-10-13 | 2025-08-01 | Hope City | Chimeric antigen receptors containing a chlorotoxin domain |
| KR20180083874A (ko) | 2015-11-04 | 2018-07-23 | 사울 제이. 프라이스맨 | Her2를 표적화하는 키메라 항원 수용체 |
| IL287889B2 (en) * | 2016-02-05 | 2024-03-01 | Hope City | Administration of engineered t cells for treatment of cancers in the central nervous system |
| EP3743445A1 (en) * | 2018-01-26 | 2020-12-02 | City of Hope | Chimeric antigen receptors and methods for reducing off target toxicity |
| WO2020028275A1 (en) * | 2018-07-30 | 2020-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Interferon-gamma biased agonists |
| EP3830133A1 (en) * | 2018-08-01 | 2021-06-09 | City of Hope | Tag72 targeted chimeric antigen receptor modified t cells for treatment of tag72-positive tumors |
| US10918667B2 (en) * | 2018-11-20 | 2021-02-16 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expressing therapeutic agent and uses thereof |
| CN119776440A (zh) * | 2020-03-09 | 2025-04-08 | 成都臻愈生物医药科技有限公司 | IFN-γ在制备抗肿瘤辅助药物中的应用 |
| CA3175123A1 (en) * | 2020-03-12 | 2021-09-16 | City Of Hope | Targeted chimeric antigen receptor modified t cells for treatment of il13r.alpha.2 positive malignancies |
-
2022
- 2022-03-30 CN CN202280026632.8A patent/CN117242090A/zh active Pending
- 2022-03-30 EP EP22718411.6A patent/EP4314040A2/en active Pending
- 2022-03-30 US US18/284,413 patent/US20240366662A1/en active Pending
- 2022-03-30 WO PCT/US2022/022575 patent/WO2022212525A2/en not_active Ceased
- 2022-03-30 JP JP2023560349A patent/JP2024514308A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530217A5 (https=) | ||
| US20240307440A1 (en) | Cell expressing a car and a transcription factor and its use | |
| JP2023071729A5 (https=) | ||
| CN107406518B (zh) | 嵌合抗原受体 | |
| JP7492561B2 (ja) | ヒト化ｂｃｍａ抗体およびｂｃｍａ－ｃａｒ－ｔ細胞 | |
| JP2023527049A5 (https=) | ||
| JP2023139070A5 (https=) | ||
| JP2022109953A5 (https=) | ||
| JP7395249B2 (ja) | 細胞 | |
| EP3472205B1 (en) | Chimeric antigen receptor | |
| ES2329334T3 (es) | Formas multimericas de ligandos de la superfamilia de tnf. | |
| JP2019517267A5 (https=) | ||
| AU776825B2 (en) | Molecules designated LDCAM | |
| JP2022541657A5 (https=) | ||
| JP2023518443A5 (https=) | ||
| JP2021525534A5 (https=) | ||
| JP2021512615A5 (https=) | ||
| JPH08507676A (ja) | 可溶性オリゴマー蛋白質の調製法 | |
| KR20220025698A (ko) | 다기능 융합 단백질 및 이의 용도 | |
| JP2007519611A (ja) | 分泌された三量体受容体類似体及び生物学的活性融合タンパク質を製造するための方法及び組成物 | |
| JP2024504728A5 (https=) | ||
| JP2026062978A (ja) | 核酸構築物 | |
| JP2022545815A5 (https=) | ||
| WO2018199595A1 (ko) | 4-1bbl 변이체 및 이를 포함하는 융합 단백질 | |
| JP2022548866A5 (https=) |